ePrints

Physicians, paraproteins and progress: Diagnosis and management of myeloma

Lookup NU author(s): Professor Graham Jackson

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.

Abstract

© 2019 MA Healthcare Ltd. Myeloma outcomes have improved dramatically over the last decade as a result of novel therapies, several of which are now commonly continued to disease relapse. Physicians who do not work in haematology are therefore more likely than ever before to be consulted by a patient with myeloma, either for an unrelated condition or with a side effect of myeloma or its treatment. Myeloma is also the cancer most likely to be diagnosed in accident and emergency departments or by the acute physician and so an awareness of its presentation and management is especially important in these settings to enable early diagnosis and limit the morbidity associated with end organ damage. This review summarizes the presenting features of disease, diagnostic criteria for myeloma and related plasma cell disorders, and discusses current management.

Publication metadata

Author(s): Pawlyn C, Jackson GH

Publication type: Review

Publication status: Published

Journal: British Journal of Hospital Medicine

Year: 2019

Volume: 80

Issue: 2

Pages: 91-98

Print publication date: 02/02/2019

Online publication date: 12/02/2019

Acceptance date: 02/04/2018

ISSN (print): 1750-8460

ISSN (electronic): 1759-7390

Publisher: MA Healthcare Ltd

URL: https://doi.org/10.12968/hmed.2019.80.2.91

DOI: 10.12968/hmed.2019.80.2.91

PubMed id: 30746991

Share